Cleveland Clinic researchers are using artificial intelligence to identify existing FDA-approved drugs that may be repurposed to treat other complex diseases. The effort is led by Feixiong Cheng, PhD, ...

The factor that tips you over the edge from being at risk for a disease to actually developing the disease is not always clear. Now, researchers from Japan report one factor that triggers problematic ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of Parkinson's disease in mice. Published in the ...

A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill University's Department of Neurology and Neurosurgery maps out the ...

A new discovery from an international collaborative research team has solved the mystery of how cells turn on their recycling ...

The trial will explore the effects of higher doses of ACD856, building on the drug’s established safety profile.

The National Institutes of Health (NIH) has proposed drastic cuts to indirect funding for research grants, impacting major ...

Glaucoma is a group of eye diseases that damage the optic nerve, which connects the eye to the brain. In most cases, glaucoma is caused by high pressure inside the eye. However, normal-tension ...

An expert has shed light on the upsides of a superfood that he claims is simple to add into your diet. Lion's mane mushrooms, ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement ...